Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan

Abstract BRCA1 and BRCA2 mutations are not uncommon in breast cancer patients. Western studies show that such mutations are more prevalent among younger patients. This study evaluates the prevalence of germline mutations in BRCA1 and BRCA2 among breast cancer patients diagnosed at age 40 or younger...

Full description

Bibliographic Details
Main Authors: Hikmat Abdel-Razeq, Lama Abujamous, Mahmoud Abunasser, Sara Edaily, Rayan Bater
Format: Article
Language:English
Published: Nature Portfolio 2021-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-94403-1